262 related articles for article (PubMed ID: 22233828)
1. A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
Mandras N; Roana J; Tullio V; Allizond V; Banche G; Scalas D; Fucale G; Cuffini AM
J Chemother; 2011 Dec; 23(6):379-80. PubMed ID: 22233828
[No Abstract] [Full Text] [Related]
2. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
[No Abstract] [Full Text] [Related]
3. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
[No Abstract] [Full Text] [Related]
4. Management of endogenous cryptococcal endophthalmitis with voriconazole.
Vela JI; Díaz-Cascajosa J; Sanchez F; Roselló N; Buil JA
Can J Ophthalmol; 2009 Dec; 44(6):e61-2. PubMed ID: 20051999
[No Abstract] [Full Text] [Related]
5. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous cryptococcosis in immunocompetent hosts.
Spiliopoulou A; Anastassiou ED; Christofidou M
Mycoses; 2012 Mar; 55(2):e45-7. PubMed ID: 22451961
[No Abstract] [Full Text] [Related]
7. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
10. New guinea pig model of Cryptococcal meningitis.
Kirkpatrick WR; Najvar LK; Bocanegra R; Patterson TF; Graybill JR
Antimicrob Agents Chemother; 2007 Aug; 51(8):3011-3. PubMed ID: 17562797
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
Yildiran ST; Fothergill AW; Sutton DA; Rinaldi MG
Mycoses; 2002 Nov; 45(9-10):378-83. PubMed ID: 12421285
[TBL] [Abstract][Full Text] [Related]
12. Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.
Choi KH; Park SJ; Min KH; Kim SR; Lee MH; Chung CR; Han HJ; Lee YC
Scand J Infect Dis; 2011 May; 43(5):380-5. PubMed ID: 21271944
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans.
Hossain MA; Maesaki S; Mitsutake K; Kakeya H; Sasaki E; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1999 Dec; 44(6):827-9. PubMed ID: 10590286
[TBL] [Abstract][Full Text] [Related]
14. Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study.
Chen YC; Chang TY; Liu JW; Chen FJ; Chien CC; Lee CH; Lu CH
BMC Infect Dis; 2015 Jul; 15():277. PubMed ID: 26194004
[TBL] [Abstract][Full Text] [Related]
15. Isolated pulmonary cryptococcosis in an immunocompetent patient.
Barbosa AT; Colares FA; Gusmão Eda S; Barros AA; Cordeiro CG; Andrade MC
J Bras Pneumol; 2006; 32(5):476-80. PubMed ID: 17268753
[TBL] [Abstract][Full Text] [Related]
16. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment.
Izumikawa K; Zhao Y; Motoshima K; Takazono T; Saijo T; Kurihara S; Nakamura S; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Hayashi T; Kohno S
Med Mycol; 2008 Sep; 46(6):595-9. PubMed ID: 19180728
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of voriconazole in experimental Cryptococcus neoformans infection.
Mavrogiorgos N; Zaragoza O; Casadevall A; Nosanchuk JD
Mycopathologia; 2006 Aug; 162(2):111-4. PubMed ID: 16897589
[TBL] [Abstract][Full Text] [Related]
18. Sarcoid-like reaction in Cryptococcus neoformans infection.
Yano S; Kobayashi K; Ikeda T; Kadowaki T; Wakabayashi K; Kimura M; Ishikawa S; Adachi Y; Araki K; Nagaoka S
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22847562
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
Silva EG; Paula CR; de Assis Baroni F; Gambale W
Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
[TBL] [Abstract][Full Text] [Related]
20. Multiple intracranial abscesses due to Cryptococcus neoformans: an unusual clinical feature in an immunocompetent patient and a short review of reported cases.
Tore O; Akcaglar S; Kazak E; Heper Y; Akalin H; Hakyemez B; Ener B; Boekhout T; Hagen F
Med Mycol; 2010 Mar; 48(2):398-401. PubMed ID: 19701854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
